News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3125last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
The Wall Street Journal164d agoneutral
J&J Mastered Cancer Biotech Deals on the Cheap. Can It Stay on the Cutting Edge?Simply Wall St.166d agoneutral
Assessing Johnson & Johnson (JNJ) Valuation After Guidance Raise Growth Initiatives And Talc Litigation Update24/7 Wall St.166d agoneutral
Inflation Adjusted Dividend Income: How to Replace $80,000 in Today’s Dollars 20 Years From NowMarketWatch166d agoneutral
Here’s the defensive stock-market trade that works no matter where bond yields end up24/7 Wall St.167d agoneutral
What a $1 Million Dividend Portfolio Actually Pays After Federal AND State Taxes in California24/7 Wall St.171d agobullish
A Monthly Dividend Portfolio That Pays Like a Pension and Beats Most Pensions on Inflation ProtectionInvesting.com179d agoneutral
JNJ gets Wall Street boost as blockbuster drug bets ignite growth hopes24/7 Wall St.179d agoneutral
The 2 US Companies With a Better Credit Rating Than Uncle Sam Belong in Every Retirement Portfolio24/7 Wall St.183d agoneutral
A $500,000 Dividend Portfolio That Pays More Than a Full-Time Minimum Wage JobReuters188d agoneutral
Factbox-Global drugmakers rush to boost US presence as tariff threat looms